SCHEMBL15680979

SCHEMBL15680979

O=S1(=O)CC2=C(CNC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL15649214 0.97 — —
SCHEMBL1394522 0.67 — —
Bromide SCHEMBL21807132 0.63 — —
Bromide SCHEMBL1394442 0.63 — —
Bromide SCHEMBL21807131 0.60 — —
SCHEMBL22908211 0.60 — —
SCHEMBL17752777 0.60 MEN1 (0.35) —
SCHEMBL17059168 0.59 — —
SCHEMBL183955 0.58 CRBN (0.44) —
SCHEMBL4730800 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150246025-A1 2-PHENYL-5-HETEROCYCLYL-TETRAHYDRO-2H-PYRAN-3-AMINE COMPOUNDS FOR USE IN THE TREATMENT OF DIABETES AND ITS ASSOCIATED DISORDERS CADILA HEALTHCARE LIMITED (IN) 2015-09-03 — — US disclosed
WO-2014061031-A1 2-PHENYL-5-HETEROCYCLYL-TETRAHYDRO-2H-PYRAN-3-AMINE COMPOUNDS FOR USE IN THE TREATMENT OF DIABETES AND ITS ASSOCIATED DISORDERS CADILA HEALTHCARE LIMITED (IN) 2014-04-24 — — WO disclosed
Send feedback